IMPEL PHARMACEUTICALS INC (IMPL)
US45258K1097 - Common Stock
| MRQ (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 15.20M | 60.65M | 88.21M | 7.10M | 37.00M | |||
| Receivables | 6.80M | 7.46M | 1.37M | 230.00K | 200.00K | |||
| Inventories | 7.00M | 8.43M | 2.82M | N/A | N/A | |||
| Other Current Assets | 3.90M | 3.27M | 2.17M | 850.00K | 2.32M | |||
| Total Current Assets | 32.90M | 79.81M | 94.58M | 8.17M | 39.53M | |||
| Non-Current Assets | ||||||||
| PPE Net | 8.40M | 7.00M | 3.15M | 3.70M | 2.74M | |||
| Other Non-Current Assets | 3.50M | 1.75M | 190.00K | 190.00K | 0.00 | |||
| Total Non-Current Assets | 11.90M | 8.74M | 3.33M | 3.89M | 2.74M | |||
| TOTAL ASSETS | 44.80M | 88.55M | 97.91M | 12.06M | 42.27M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 420.00K | 0.00 | |||
| Accrued Expenses | 13.50M | 13.78M | 8.95M | 3.17M | 4.23M | |||
| Accounts Payable | 3.50M | 6.09M | 6.37M | 4.31M | 2.73M | |||
| Other Current Liabilities | 104.20M | 2.29M | 640.00K | 2.62M | 1.37M | |||
| Total Current Liabilities | 121.20M | 22.16M | 15.95M | 10.53M | 8.32M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 48.07M | 29.45M | 7.99M | 0.00 | |||
| Other Non-Current Liabilities | 2.70M | 62.47M | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 2.80M | 110.55M | 29.45M | 7.99M | 0.00 | |||
| TOTAL LIABILITIES | 124.00M | 132.71M | 45.40M | 18.52M | 8.32M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -358.50M | -321.11M | -214.80M | -138.26M | -92.46M | |||
| Additional Paid In Capital | 279.40M | 276.93M | 267.28M | 4.76M | 760.00K | |||
| Common Shares | 0.00 | 20.00K | 20.00K | 127.04M | 125.65M | |||
| Shares Outstanding | 23.70M | 23.74M | 23.12M | 19.41M | 19.41M | |||
| Tangible Book Value per Share | -3.34 | -1.86 | 2.27 | -6.88 | -4.72 | |||
| Total Shareholders' Equity | -79.20M | -44.16M | 52.51M | -6.46M | 33.94M | |||
| TOTAL LIABILITIES AND EQUITY | 44.80M | 88.55M | 97.91M | 12.06M | 42.27M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | -1.09 | 0.56 | -1.24 | N/A | |||
| Current Ratio | 0.27 | 3.60 | 5.93 | 0.78 | 4.75 | |||
| Return On Assets (ROA) | -204.40% | -120.06% | -78.31% | -384.08% | -100.21% | |||
| Return On Equity (ROE) | N/A | N/A | -146.01% | N/A | -124.81% | |||
All data in USD